AGP Executive Report
Last update: 7 hours agoCBD Coverage (Medicare/Travel/Policy): The FDA says it won’t interfere with a new CMS policy that lets Medicare beneficiaries get coverage for certain hemp-derived CBD products, with limits on THC content and a ban on inhalable forms; Travel Guidance: TSA updated its medical marijuana travel guidance, clarifying how patients can bring state-licensed cannabis for use after arrival; Medical Use in Practice: A Fiji hospital conference heard that some teens first tried cannabis or meth as early as Years 4–5, with doctors urging empathy and earlier family awareness; Regulation Watch: Australia’s top neurologists say they were ignored by the regulator during the review of paraquat, a weedkiller tied to Parkinson’s disease, as a final decision nears; Industry/Legal Pressure: Bayer warned that glyphosate litigation could threaten U.S. production, keeping pressure on major weed-control supply chains.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
